JAZZEarnings Release财报快讯Media source媒体来源Source link原始来源by InvestLog AIInvestLog AI 整理

Event time: 事件时间：02/11/2026 21:05:00 UTC2026/11/02 21:05:00 UTC

Published: 文章发布：02/11/2026 21:23:16 UTC2026/11/02 21:23:16 UTC

JAZZ earnings release — EPS beat · revenue beat +2.9%爵士制药 (JAZZ) 财报发布 — EPS 高于预期 · 营收高于预期+2.9%

Key Results

EPS: -$3.88 vs -$4.05 estimate, beat.

Revenue: $1.2B vs $1.2B estimate, beat+2.9%.

Period: 2026 Q3 period ended 2026-09-30

Revenue: $1.2B; YoY: +10.4%; QoQ: +2.9%

Operating income: -$413M; Operating margin: -33.3%

Net income: -$483M; GAAP diluted EPS: -$7.48

Operating cash flow: $506M; Capex: $16M; Free cash flow: $490M

Cash: $2.0B; Total debt: $1.1B; Net cash: $958M

Official release: Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results

EPS：-$3.88 vs -$4.05 预期，高于预期。

营收：$1.2B vs $1.2B 预期，高于预期+2.9%。

期间：2026 Q3（截至 2026-09-30）

营收：$1.2B；同比：+10.4%；环比：+2.9%

经营利润：-$413M；经营利润率：-33.3%

净利润：-$483M；GAAP 稀释 EPS：-$7.48

经营现金流：$506M；资本开支：$16M；自由现金流：$490M

现金：$2.0B；总债务：$1.1B；净现金：$958M

For information only. Not investment advice.内容仅供参考，不构成投资建议。